ArticleBMC cancer2023

Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias.

Daichi Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.